Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 253

Tiger Brokers catches $104m in IPO

The Xiaomi-backed online brokerage floated above its range while its other corporate investor, International Brokers, bought more than $13m of shares.

Mar 21, 2019

Pine Labs to swipe Qwikcilver for $110m

The gift card services provider is set be acquired by Pine Labs in a $110m deal, after raising more than $21m from investors including Amazon and Sistema.

Mar 21, 2019

Innogy finds exit hatch at Airec

Innogy's corporate venturing unit has offloaded its stake in heat exchanger producer Airec to Alfa Laval and Sveper Heat Transfer.

Mar 21, 2019

Stryker gathers OrthoSpace in $220m deal

Smith & Nephew and Johnson & Johnson have exited the shoulder implant developer in an all-cash acquisition by Stryker that could reach $220m.

Mar 20, 2019

Wanda and Vortex to vacate stage

Embattled commercialisation firm NetScientific is closing two medical diagnostics spinouts from UCLA after both failed to attract external funding.

Mar 19, 2019

36Kr seeks lowdown in $100m IPO

36Kr Media is considering an initial public offering in the US that would be sized at about $100m, providing exits for Baidu Video and Focus Media Information Technology.

Mar 19, 2019

Alcon sees way to $285m PowerVision acquisition

Alcon acquired the intraocular lens developer in a $285m deal that follows $106m in funding from investors including its parent company Novartis as well as Johnson & Johnson and Medtronic.

Mar 19, 2019

Minute Media takes on The Big Lead

Minute Media has purchased the sports blogging and media platform for an undisclosed amount, allowing Gannett to exit.

Mar 19, 2019

Lyft accelerates towards $2.1bn IPO target

Lyft has set the range for an IPO that would allow Alphabet, Rakuten, GM, Jaguar Land Rover, Alibaba, Didi Chuxing, Magna and Icahn Enterprises to exit, valuing it at up to $22.9bn.

Mar 18, 2019

NervGen Pharma holds nerve for $7.5m IPO

CWRU-licensed NervGen Pharma floated at the top of its range on the TSX Venture Exchange, with the proceeds earmarked to push its lead candidate for spinal cord injury into the clinic.

Mar 18, 2019
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here